Date(s) - June 12,2020 - June 14,2020
8:00 am - 1:00 pm
Park Central San Francisco
Friday, June 12, 2020
Dr. Kathleen Besinque, PharmD.,M.S.Ed., FASHP, FCSHP, FCPhA
Chapman University School of Pharmacy
Dr. Kathleen Besinque is a Professor of Pharmacy and the Director of Experiental Education at Chapman University School of Pharmacy. Her clinical practice area is community pharmacy and she specializes in women’s health and public health issues. She is actively involved at the leadership level with several professional organizations including the California Pharmacists Association, the Association of Reproductive Health Professionals, the California society of Health-Systems Pharmacists, and the American Association of Colleges of Pharmacy.
ACPE # 0043-9999-18-008-L01-P
1. Describe the mechanism of action for currently available contraceptives.
2. Compare the currently available contraceptives (pills, patches, rings, implants, IUDs, and barriers) with respect to efficacy, side effects, and safety.
3. Explain proper use of contraceptives to patients seeking advice from the pharmacist.
4. Assist men/women in the selection of a contraceptive that meets their individual needs.
5. Counsel patients about the management of adverse effects from contraceptive formulations.
6. Differentiate symptoms of menopause and aging in women.
7. Compare currently available products including hormones and complimentary therapies for managing the symptoms of menopause.
8. Evaluate the risks and benefits of hormone therapy based upon current research.
9. Counsel women seeking relief from menopausal symptoms.
10. Describe the physiological changes resulting in osteoporosis.
11. Advise patients regarding strategies to prevent osteoporosis.
12. Compare pharmacological agents to prevent and treat osteoporosis.
13. Discuss the role of Vitamin D in preventing and treating bone loss.
Saturday June 13, 2020
Dr. Susie Park, Pharm D., BCPP
University of Southern California
Dr. Susie Park received her Pharm D. from the USC School of Pharmacy. She completed a one-year residency in psychiatric pharmacy practice and subsequently obtained the Board of Pharmaceutical Specialty in psychiatry. Currently, she is an Associate Professor of Clinical Pharmacy and Pharmaceutical Economics and Policy. Her ongoing research projects include pharmacogenetics of psychiatry and identifying relationships between genomic markers and psychiatric disease and other chronic diseases such as hepatitis C and HIV.
ACPE # TBA
ACPE # TBA